Complementary and alternative therapies for post-caesarean pain.

CONCLUSIONS: Some CAM therapies may help reduce post-CS pain for up to 24 hours. The evidence on adverse events is too uncertain to make any judgements on safety and we have no evidence about the longer-term effects on pain. Since pain control is the most relevant outcome for post-CS women and their clinicians, it is important that future studies of CAM for post-CS pain measure pain as a primary outcome, preferably as the proportion of participants with at least moderate (30%) or substantial (50%) pain relief. Measuring pain as a dichotomous variable would improve the certainty of evidence and it is easy to understand for non-specialists. Future trials also need to be large enough to detect effects on clinical outcomes; measure other important outcomes as listed lin this review, and use validated scales. PMID: 32871021 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Tags: Cochrane Database Syst Rev Source Type: research

Related Links:

If you ask health care providers about the most challenging condition to treat, chronic pain is mentioned frequently. By its nature, chronic pain is a complex and multidimensional experience. Pain perception is affected by our unique biology, our mood, our social environment, and past experiences. If you or a loved one is suffering from chronic pain, you already know the heavy burden. People are looking for novel, nonaddictive ways to treat pain Given the ongoing challenges of chronic pain management coupled with the consequences of the opioid epidemic, pain management practitioners and their patients are searching for eff...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Back Pain Marijuana Pain Management Source Type: blogs
Conditions:   First Pregnancy;   Vaginal Delivery Intervention:   Other: Therapeutic touch Sponsor:   Cumhuriyet University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Abstract Marijuana is the most commonly used illicit substance under federal law in the United States (1); however, many states have legalized medical and adult nonmedical use. Evidence regarding the safety and health effects of cannabis use during pregnancy is largely inconclusive (2). Potential adverse health effects to exposed infants (e.g., lower birthweight) have been documented (2). To provide population-based estimates of use surrounding pregnancy, identify reasons for and mode of use, and understand characteristics of women who continue versus cease marijuana use during pregnancy, CDC analyzed data from ei...
Source: MMWR Morb Mortal Wkl... - Category: Epidemiology Authors: Tags: MMWR Morb Mortal Wkly Rep Source Type: research
This article idea was suggested by a Conscious Growth Club member. After a little reflection, I thought, why not? I’ve seen every episode of every non-animated Star Trek series, including the original 1960s classic, The Next Generation, Deep Space Nine, Voyager, Enterprise, Discovery, and the new Picard series. I’ve seen many episodes multiple times. I’ve seen all of the movies. I’ve been to a Star Trek Convention in Las Vegas. So I’m pretty well versed in Star Trek lore. I met William Shatner (aka Captain Kirk) very briefly when I was in my 20s because we had the same lawyer for a while...
Source: Steve Pavlina's Personal Development Blog - Category: Psychiatry & Psychology Authors: Tags: Lifestyle Values Source Type: blogs
TITUSVILLE, N.J. – (August 3, 2020) – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation orbehavior.1 SPRAVATO® is the first and only approved medicine that has been shown to reduce depressive symptoms within 24 hours,1 providing a new option for significant symptom relief until a longer-ter...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
The objective of this study was to investigate the association of physical activity, weight status, anxiety, and evolution of LBPP symptoms in postpartum women.
Source: Journal of Manipulative and Physiological Therapeutics - Category: Complementary Medicine Authors: Source Type: research
Condition:   Childbirth Fear, Anxiety,Birth Pain Intervention:   Other: applied forms to pregnant women Sponsor:   Saglik Bilimleri Universitesi Gulhane Tip Fakultesi Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acupuncture | Alternative and Complementary Therapies | Anxiety | Aromatherapy | Cardiology | Clinical Trials | Complementary Medicine | Databases & Libraries | General Medicine | Heart | Pain | Perinatology & Neonatology | Pregnancy | Respiratory Medicine | Study | TENS | Women